Menten AI is a pioneering biotechnology company that combines quantum computing, artificial intelligence, and protein engineering to revolutionize drug discovery and design. Founded in 2018 by CEO Vikram Mulligan and leveraging research from the Baker Lab at the University of Washington, the company uses quantum-enhanced algorithms to solve complex protein folding and design problems that are computationally intractable for classical computers. Menten AI’s platform enables the design of novel protein therapeutics, including peptides and small proteins, by exploring vast sequence spaces and optimizing for desired properties such as stability, specificity, and manufacturability. The company’s quantum computing approach provides advantages in sampling complex conformational states and optimizing multi-objective design problems inherent in drug discovery. Menten AI has developed a pipeline of proprietary therapeutic candidates and offers computational design services to pharmaceutical partners. Their technology represents a convergence of quantum computing and biotechnology that could accelerate the development of new medicines for diseases including cancer, autoimmune disorders, and infectious diseases.
Vikram Mulligan (Founder, CEO)
Explore other quantum computing companies in similar categories or regions.
Private
$26M
2 funding rounds tracked. View detailed investment history β
Information for Educational Purposes Only: All information about Menten AI is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of Menten AI's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.